WASHINGTON, D.C. – September 11, 2015 – The COPD Foundation, a nonprofit organization dedicated to curing chronic obstructive pulmonary disease (COPD), in association with Novartis Pharma, will host three respiratory “hackathon” events, entitled Breathe Hackathons. The events will bring together designers, technicians, engineers, patients, physicians, and entrepreneurs to investigate solutions to many of the problems COPD patients face daily. COPD is a condition that affects an estimated 30 million Americans and over 250 million individuals worldwide. It is the third leading cause of death in the United States, and is characterized by increased wheezing and breathlessness.
Over two days in Boston, London, and Tel Aviv, innovators from around the world will meet to “hack” into medical equipment for respiratory use such as CPAP devices, nebulizers, oxygen concentrators, and sleep monitors in the hopes of integrating different solutions under a common platform to ultimately offer better health outcomes and improved quality of life for patients. These events will be held in three countries; September 19 and 20th at the Massachusetts Institute of Technology (MIT) Media Lab and at the Imperial College of Science and Technology, and on September 20 and 21st at Technion, the Israel Institute of Technology. Hackers from each school will be competing along with industry experts, COPD patients, and professionals in an effort to develop what could be the next big technology solution to a worldwide lung health epidemic.